# BBX Capital, Inc.: financial statements, quarterly

BBXIB · OTC · CIK 1814974 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbxib.md) · [Financials](/companies/bbxib/financials.md) · [Filings](/companies/bbxib/filings.md) · [Insiders](/companies/bbxib/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbxib/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [72.2](/filings/0001437749-23-013589.md) | [81.3](/filings/0001437749-23-022788.md) | [72.7](/filings/0001437749-23-030942.md) | [81.9 d](/filings/0001437749-25-008868.md) | [92.1](/filings/0001437749-24-015998.md) | [105](/filings/0001437749-24-025865.md) | [98.2](/filings/0001437749-24-034466.md) | [93.7 d](/filings/0001437749-25-008868.md) | [78.5](/filings/0001437749-24-015998.md) | [73.3](/filings/0001437749-24-025865.md) | [75.0](/filings/0001437749-24-034466.md) | [71.1 d](/filings/0001437749-25-008868.md) |
| Selling, general and administrative | $m | [27.4](/filings/0001437749-23-013589.md) | [30.1](/filings/0001437749-23-022788.md) | [29.1](/filings/0001437749-23-030942.md) | [29.7 d](/filings/0001437749-25-008868.md) | [33.8](/filings/0001437749-24-015998.md) | [34.3](/filings/0001437749-24-025865.md) | [34.1](/filings/0001437749-24-034466.md) | [34.0 d](/filings/0001437749-25-008868.md) | [35.4](/filings/0001437749-24-015998.md) | [33.3](/filings/0001437749-24-025865.md) | [34.2](/filings/0001437749-24-034466.md) | [32.7 d](/filings/0001437749-25-008868.md) |
| Operating income | $m | [(5.1)](/filings/0001437749-23-013589.md) | [(3.1)](/filings/0001437749-23-022788.md) | [(9.1)](/filings/0001437749-23-030942.md) | [19.8 d](/filings/0001437749-25-008868.md) | [(11.1)](/filings/0001437749-24-015998.md) | [(9.7)](/filings/0001437749-24-025865.md) | [(9.6)](/filings/0001437749-24-034466.md) | [(14.9) d](/filings/0001437749-25-008868.md) | [(16.8)](/filings/0001437749-24-015998.md) | [(14.6)](/filings/0001437749-24-025865.md) | [(11.3)](/filings/0001437749-24-034466.md) | [(19.7) d](/filings/0001437749-25-008868.md) |
| Interest expense | $m | [0.5](/filings/0001437749-23-013589.md) | [0.5](/filings/0001437749-23-022788.md) | [0.6](/filings/0001437749-23-030942.md) | [0.7 d](/filings/0001437749-25-008868.md) | [0.7](/filings/0001437749-24-015998.md) | [0.7](/filings/0001437749-24-025865.md) | [0.8](/filings/0001437749-24-034466.md) | [0.9 d](/filings/0001437749-25-008868.md) | [0.9](/filings/0001437749-24-015998.md) | [0.6](/filings/0001437749-24-025865.md) | [0.7](/filings/0001437749-24-034466.md) | [0.9 d](/filings/0001437749-25-008868.md) |
| Income tax | $m | [(0.8)](/filings/0001437749-23-013589.md) | [6.2](/filings/0001437749-23-022788.md) | [2.5](/filings/0001437749-23-030942.md) | [7.3 d](/filings/0001437749-25-008868.md) | [1.7](/filings/0001437749-24-015998.md) | [(1.3)](/filings/0001437749-24-025865.md) | [(0.6)](/filings/0001437749-24-034466.md) | [(1.8) d](/filings/0001437749-25-008868.md) | [(2.7)](/filings/0001437749-24-015998.md) | [(2.4)](/filings/0001437749-24-025865.md) | [(2.0)](/filings/0001437749-24-034466.md) | [14.8 d](/filings/0001437749-25-008868.md) |
| Net income | $m | [(1.8)](/filings/0001437749-23-013589.md) | [10.5](/filings/0001437749-23-022788.md) | [4.0](/filings/0001437749-23-030942.md) | [15.4 d](/filings/0001437749-25-008868.md) | [7.9](/filings/0001437749-24-015998.md) | [(8.0)](/filings/0001437749-24-025865.md) | [(7.8)](/filings/0001437749-24-034466.md) | [(12.9) d](/filings/0001437749-25-008868.md) | [(13.0)](/filings/0001437749-24-015998.md) | [(10.0)](/filings/0001437749-24-025865.md) | [(9.9)](/filings/0001437749-24-034466.md) | [(31.0) d](/filings/0001437749-25-008868.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001437749-23-013589.md) | [0.68](/filings/0001437749-23-022788.md) | [0.26](/filings/0001437749-23-030942.md) | not reported | [0.55](/filings/0001437749-24-015998.md) | [(0.56)](/filings/0001437749-24-025865.md) | [(0.55)](/filings/0001437749-24-034466.md) | not reported | [(0.94)](/filings/0001437749-24-015998.md) | [(0.74)](/filings/0001437749-24-025865.md) | [(0.74)](/filings/0001437749-24-034466.md) | not reported |
| Basic EPS | $ per share | [(0.12)](/filings/0001437749-23-013589.md) | [0.68](/filings/0001437749-23-022788.md) | [0.26](/filings/0001437749-23-030942.md) | not reported | [0.55](/filings/0001437749-24-015998.md) | [(0.56)](/filings/0001437749-24-025865.md) | [(0.55)](/filings/0001437749-24-034466.md) | not reported | [(0.94)](/filings/0001437749-24-015998.md) | [(0.74)](/filings/0001437749-24-025865.md) | [(0.74)](/filings/0001437749-24-034466.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [115](/filings/0001437749-23-013589.md) | [118](/filings/0001437749-23-022788.md) | [98.5](/filings/0001437749-23-030942.md) | [128](/filings/0001437749-25-008868.md) | [95.0](/filings/0001437749-24-015998.md) | [81.5](/filings/0001437749-24-025865.md) | [102](/filings/0001437749-24-034466.md) | [90.3](/filings/0001437749-25-008868.md) | [108](/filings/0001437749-24-015998.md) | [116](/filings/0001437749-24-025865.md) | [93.4](/filings/0001437749-24-034466.md) | [87.7](/filings/0001437749-25-008868.md) |
| Total assets | $m | [532](/filings/0001437749-23-013589.md) | [543](/filings/0001437749-23-022788.md) | [546](/filings/0001437749-23-030942.md) | [563](/filings/0001437749-25-008868.md) | [685](/filings/0001437749-24-015998.md) | [674](/filings/0001437749-24-025865.md) | [681](/filings/0001437749-24-034466.md) | [674](/filings/0001437749-25-008868.md) | [658](/filings/0001437749-24-015998.md) | [646](/filings/0001437749-24-025865.md) | [642](/filings/0001437749-24-034466.md) | [603](/filings/0001437749-25-008868.md) |
| Total liabilities | $m | [210](/filings/0001814974-22-000051.md) | [210](/filings/0001814974-22-000092.md) | [209](/filings/0001814974-22-000118.md) | [224](/filings/0001437749-24-008085.md) | [273](/filings/0001437749-23-013589.md) | [269](/filings/0001437749-23-022788.md) | [292](/filings/0001437749-23-030942.md) | [303](/filings/0001437749-25-008868.md) | [297](/filings/0001437749-24-015998.md) | [297](/filings/0001437749-24-025865.md) | [302](/filings/0001437749-24-034466.md) | [294](/filings/0001437749-25-008868.md) |
| Shareholders' equity | $m | [321](/filings/0001814974-22-000051.md) | [331](/filings/0001814974-22-000092.md) | [334](/filings/0001814974-22-000118.md) | [334](/filings/0001437749-24-008085.md) | [342](/filings/0001437749-23-013589.md) | [336](/filings/0001437749-23-022788.md) | [329](/filings/0001437749-23-030942.md) | [312](/filings/0001437749-25-008868.md) | [299](/filings/0001437749-24-015998.md) | [286](/filings/0001437749-24-025865.md) | [278](/filings/0001437749-24-034466.md) | [246](/filings/0001437749-25-008868.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.4)](/filings/0001437749-23-013589.md) | [14.0 d](/filings/0001437749-23-022788.md) | [11.3 d](/filings/0001437749-23-030942.md) | [19.4 d](/filings/0001437749-25-008868.md) | [(13.7)](/filings/0001437749-24-015998.md) | [5.7 d](/filings/0001437749-24-025865.md) | [13.4 d](/filings/0001437749-24-034466.md) | [(16.7) d](/filings/0001437749-25-008868.md) | [(28.9)](/filings/0001437749-24-015998.md) | [7.1 d](/filings/0001437749-24-025865.md) | [(7.6) d](/filings/0001437749-24-034466.md) | [(4.6) d](/filings/0001437749-25-008868.md) |
| Capital expenditure | $m | [1.9](/filings/0001437749-23-013589.md) | [4.1 d](/filings/0001437749-23-022788.md) | [4.1 d](/filings/0001437749-23-030942.md) | [4.7 d](/filings/0001437749-25-008868.md) | [5.4](/filings/0001437749-24-015998.md) | [3.6 d](/filings/0001437749-24-025865.md) | [1.9 d](/filings/0001437749-24-034466.md) | [4.2 d](/filings/0001437749-25-008868.md) | [1.8](/filings/0001437749-24-015998.md) | [2.2 d](/filings/0001437749-24-025865.md) | [1.0 d](/filings/0001437749-24-034466.md) | [2.2 d](/filings/0001437749-25-008868.md) |
| Share repurchases | $m | not reported | not reported | [1.0 d](/filings/0001437749-23-030942.md) | [0.0 d](/filings/0001437749-25-008868.md) | not reported | not reported | [0.0 d](/filings/0001437749-24-034466.md) | [0.0 d](/filings/0001437749-25-008868.md) | not reported | not reported | [0.0 d](/filings/0001437749-24-034466.md) | [0.0 d](/filings/0001437749-25-008868.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001814974-22-000051.md) | [0.0](/filings/0001814974-22-000092.md) | [0.0](/filings/0001814974-22-000118.md) | [15.5](/filings/0001437749-23-013589.md) | [15.5](/filings/0001437749-23-022788.md) | [15.5](/filings/0001437749-23-030942.md) | [14.4](/filings/0001437749-24-015998.md) | [14.4](/filings/0001437749-24-025865.md) | [14.4](/filings/0001437749-24-034466.md) | [13.9](/filings/0001437749-24-015998.md) | [13.6](/filings/0001437749-24-025865.md) | [13.4](/filings/0001437749-24-034466.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.